WithdrawnPhase 2NCT04943302

Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis

Studying AL amyloidosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tufts Medical Center
Principal Investigator
Cindy Varga, MD, MD
Tufts Medical Center
Intervention
Bendamustine Hydrochloride(drug)
Eligibility
18 years · All sexes
Timeline
20222026

Collaborators

Sanofi

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04943302 on ClinicalTrials.gov

Other trials for AL amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for AL amyloidosis

← Back to all trials